Outcome of treatment after first relapse in younger adults with acute myeloid leukemia initially treated by the ALFA-9802 trial
Leukemia Research, 07/27/2012
Thomas X et al. – The authors conclude that most adult patients with recurring acute myeloid leukemia (AML) could not be rescued using current available therapies, although allogeneic stem cell transplant (SCT) remains the best therapeutic option at this stage of the disease.



